Hypersensitivity pneumonitis — RCPSC IM MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Refer for progressive-fibrotic-ILD therapy and transplant assessment
The best answer is “Refer for progressive-fibrotic-ILD therapy and transplant assessment”. Progressive fibrotic disease despite antigen avoidance requires specialist reassessment for immunomodulatory or antifibrotic strategies, pulmonary rehabilitation, oxygen needs and transplant timing. Waiting for advanced hypoxemia loses opportunity. Serial physiology, symptoms and imaging establish progression and help distinguish irreversible fibrosis from an inflammatory component that may respond to treatment.
Reference: Canadian Thoracic Society, 2023 COPD pharmacotherapy guideline: https://cts-sct.ca/guideline-library/